Breast cancer recurrence and screening: case report in a patient with HER2+

Authors

  • Enrique Avila-Monteverde
  • Alexia M. Vásquez-Galaz Universidad de Sonora
  • Ana C. Névarez-López Universidad de Sonora
  • Ángel M. Sánchez-González Universidad de Sonora
  • Sofía Montiel-Celaya Universidad de Sonora

DOI:

https://doi.org/10.59420/remus.10.2023.179

Keywords:

Breast cancer, Tumor recurrence, Early detection, Multidisciplinary treatment

Abstract

Breast cancer is a malignant disease characterized by the abnormal growth of breast tissue. It is the most prevalent and deadly neoplasm in Mexico. Diagnosis is based on physical examination, ultrasound, and mammography. Screening begins at age 40. Treatment is multidisciplinary and includes radical or conservative surgery with axillary lymph node dissection or sentinel node biopsy, radiation therapy, chemotherapy, among others. The risk of recurrence is prolonged and persists for more than a decade after treatment.

The case of a 51-year-old woman with a family history of breast cancer and a history of quadrantectomy, laparoscopy for endometriosis, and resection of breast nodules is presented.

She experienced recurrence of breast cancer that led to left radical mastectomy and eight cycles of chemotherapy. The rapid recurrence after last follow-up assessment is accentuated. 

A review of the Clinical Practice Guidelines of the National Center of Technological Excellence in Health (CENETEC) and databases such as PubMed, Scielo and INEGI were consulted. The approach was retrospective, analyzing the patient's medical records and laboratory results. The importance of early detection and adequate follow-up in patients with significant histories is highlighted.

Downloads

Download data is not yet available.

References

Zhao X, Yang X, Gao R, Zhai L, Yang L, Yu K. HER2- Positive Pure Mucinous Breast Carcinoma: A Case Report and Literature Re-view. Medicine 2020; 99:33(e20996).https://doi.org/10.1097%2FMD.0000000000020996

Weigelt, Britta et al. “Histological Types of Breast Cancer: How Special Are They?.” Mo-lecular Oncologyvol, 4,3 (2010): 192-208. https://doi.org/10.1016/j.molonc.2010.04.004

Horvath E et al. Subtipos moleculares del cáncer mamario - lo que el radiólogo dedica-do a imágenes mamarias debe saber. Rev Chil Radiol 2021; 27(1):17-26.http://dx.doi.org/10.4067/S0717-93082021000100017

Instituto Nacional de Salud Pública (INSP). Práctica Médica Efectiva; Cáncer de mama. Morelos, México; (2007].https://www.insp.mx/images/storie s/Centros/nucleo/docs/pme_19.pdf

Estadísticas a propósito del Día Internacional de la Lucha contra el Cáncer de Mama (19 de octubre). Instituto Nacional de Estadística y Geografía (INEGI). Ciudad de México; [2022]. https://www.inegi.org.mx/contenid os/sala-deprensa/aproposito/2022/E AP_CANMA-MA22.pdf

Diagnóstico y Tratamiento de la Patología Mamaria Benigna en Primer y Segundo Nivel de Atención, México; Instituto Mexicano del Seguro Social, 2011.https://www.imss.gob.mx/sites/all/statics/guiasclinicas/240GRR.pdf

Prevención tamizaje y referencia oportuna de casos sospechosos de cáncer de mama en el primer nivel de atención. Guía de Evidencias y Recomendaciones: Guía de Práctica Clínica. México: CENETEC; 2017 [2023]. http://cenetec-difusion.com/gpc-sns/?p=490

Gonzalez-Pérez A. Valor del ultrasonido en la detección de recurrencia loco-regional durante la vigilancia de pacientes con cáncer de mama. 2023; Tesis Doctoral. Universidad Autónoma de Nuevo Leon: 2-14. http://eprints.uanl.mx/24524/

Gu Y, Bui T, Muller WJ. Exploiting Mouse Models to Recapitulate Clinical Tumor Dormancy and Recurrence in Breast Cancer. Endocrinology. 2022 Jun 1; 163(6):bqac055. https://doi.org/10.1210/endocr/bqac055

Ruiz-Cornejo, G. Factores relacionados para la recurrencia de cáncer de mama evaluados por mamografía espectral clínica oncosa-lud 2019. 2022; Tesis de pregrado, Universidad Nacional Federico Villareal: 10-31. http://repositorio.unfv.edu.pe/handle/UNFV/6006

Case Report Cover: Breast Cancer Recurrence and Screening — Case Report in a HER2+ Patient

Published

2023-12-31

How to Cite

Avila-Monteverde , E., Vásquez-Galaz, A. M., Névarez-López, A. C., Sánchez-González, Ángel M., & Montiel-Celaya, S. (2023). Breast cancer recurrence and screening: case report in a patient with HER2+. REMUS - Revista Estudiantil De Medicina De La Universidad De Sonora, 5(2). https://doi.org/10.59420/remus.10.2023.179

Issue

Section

Clinical case presentation

Metrics